Biomarkers predict time to ovarian cancer recurrence

Ovarian cancer often remains undetected until it is at an advanced stage. Despite positive responses to initial treatment, many patients are at risk of tumor recurrence. A multitude of genetic markers have been implicated in ovarian cancer prognosis. However, the genetic testing required is not practical or affordable in a clinical setting.

In this issue of the Journal of Clinical Investigation, Roel Verchaak and colleagues at the MD Anderson Cancer Center identify protein biomarkers that are predictive for time of ovarian and develop a PRotein-driven index of OVARian cancer (PROVAR).

Using PROVAR, the authors were able to discriminate between patients with high and low risk of cancer recurrence, as well as short-term and long-term survival prognosis. In combination with genetic diagnosis, analysis of may be useful in predicting outcome and determining a treatment plan for ovarian cancer patients.

More information: Predicting Time to Ovarian Carcinoma Recurrence Using Protein Markers, J Clin Invest. DOI: 10.1172/JCI68509

add to favorites email to friend print save as pdf

Related Stories

Key find for early bladder cancer treatment

May 23, 2013

Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

Recommended for you

Ascertaining low-dose radiation impact on the heart

11 minutes ago

We are all exposed to radiations. Such exposure can be harmless at very low doses but damage our health above certain thresholds. But what happens in between is more difficult to predict. The PROCARDIO project is casting ...

Incomplete HPV vaccination may offer some protection

17 hours ago

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated. These findings appear in the journal ...

New imaging agent provides better picture of the gut

17 hours ago

A multi-institutional team of researchers has developed a new nanoscale agent for imaging the gastrointestinal (GI) tract. This safe, noninvasive method for assessing the function and properties of the GI tract in real time ...

User comments